Hackensack Cancer Center, MSKCC Form Business, Clinical Partnership in New Jersey December 16, 2016Vol.42 No.46By Paul Goldberg
Drugs & Targets Verastem licenses exclusive worldwide rights to develop and commercialize Infinity’s oncology product candidate duvelisib. December 11, 2016Vol.42 No.42
In Brief NCCN imaging appropriate use criteria published for 15 guidelines December 02, 2016Vol.42 No.44
Drugs & Targets First computer-aided detection system gets FDA approval December 02, 2016Vol.42 No.44
Drugs & Targets BMS, Enterome collaborate on microbiome-derived biomarkers December 02, 2016Vol.42 No.44
